Moors & Cabot Inc. Has $537,000 Stake in Monsanto (NYSE:MON)

Moors & Cabot Inc. cut its stake in shares of Monsanto (NYSE:MON) by 14.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,580 shares of the basic materials company’s stock after selling 800 shares during the quarter. Moors & Cabot Inc.’s holdings in Monsanto were worth $537,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Gradient Investments LLC bought a new position in Monsanto during the fourth quarter worth $108,000. Americafirst Capital Management LLC bought a new position in Monsanto during the third quarter worth $148,000. Truewealth LLC bought a new position in shares of Monsanto in the fourth quarter valued at $163,000. S&CO Inc. bought a new position in shares of Monsanto in the third quarter valued at $216,000. Finally, McKinley Carter Wealth Services Inc. bought a new position in shares of Monsanto in the fourth quarter valued at $218,000. 76.25% of the stock is currently owned by institutional investors and hedge funds.

A number of research firms have weighed in on MON. Royal Bank of Canada reaffirmed a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Wednesday, November 15th. Wells Fargo & Co reaffirmed a “market perform” rating and issued a $128.00 price objective (up from $118.00) on shares of Monsanto in a research note on Wednesday, January 17th. Deutsche Bank reaffirmed a “buy” rating on shares of Monsanto in a research note on Tuesday, January 16th. Finally, Zacks Investment Research lowered shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, December 11th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Monsanto currently has a consensus rating of “Hold” and a consensus price target of $127.30.

Shares of Monsanto (NYSE:MON) traded down $0.44 during mid-day trading on Wednesday, hitting $123.15. 3,513,183 shares of the stock traded hands, compared to its average volume of 3,110,000. The stock has a market capitalization of $54,280.00, a P/E ratio of 22.76, a P/E/G ratio of 1.76 and a beta of 0.95. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.79 and a current ratio of 1.28. Monsanto has a 52 week low of $111.92 and a 52 week high of $124.20.

Monsanto (NYSE:MON) last announced its earnings results on Thursday, January 4th. The basic materials company reported $0.41 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01). The firm had revenue of $2.66 billion during the quarter, compared to analysts’ expectations of $2.77 billion. Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The business’s revenue for the quarter was up .3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.21 EPS. equities research analysts predict that Monsanto will post 5.76 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, April 6th will be issued a $0.54 dividend. The ex-dividend date is Thursday, April 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.75%. Monsanto’s dividend payout ratio is currently 39.93%.

In other news, EVP Steven Mizell sold 8,100 shares of the stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the sale, the executive vice president now owns 56,743 shares in the company, valued at $6,772,277.05. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.70% of the company’s stock.

WARNING: “Moors & Cabot Inc. Has $537,000 Stake in Monsanto (NYSE:MON)” was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with's FREE daily email newsletter.

Leave a Reply